Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?

Walrand, Stephan;Flux, Glenn D;Konijnenberg, Mark W;Valkema, Roelf;Jamar, François;et.al.
(2011) European Journal of Nuclear Medicine and Molecular Imaging — Vol. 38, n° Suppl. 1, p. S57-568 (2011)

Files

EurJNuclMedImaging.pdf
  • Open Access
  • Adobe PDF
  • 451.13 KB
Download

Details

Authors
  • Walrand, StephanUCLouvain
    Author
  • Flux, Glenn D
    Author
  • Konijnenberg, Mark W
    Author
  • Valkema, Roelf
    Author
  • Lhommel, Renaudorcid-logoUCLouvain
    Author
  • Pauwels, StanislasUCLouvain
    Author
  • Jamar, FrançoisUCLouvain
    Author
Show more
Abstract
This paper reviews issues concerning (86)Y positron emission tomography (PET), (90)Y PET and (90)Y bremsstrahlung imaging. Specific methods and corrections developed for quantitative imaging, for application in preclinical and clinical studies, and to assess (90)Y dosimetry are discussed. The potential imaging capabilities with the radioisotopes (87)Y and (88)Y are also considered. Additional studies required to assess specific unaddressed issues are also identified.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Walrand, S., Flux, G. D., Konijnenberg, M. W., Valkema, R., Krenning, E. P., Lhommel, R., Pauwels, S., & Jamar, F. (2011). Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging? European Journal of Nuclear Medicine and Molecular Imaging, 38(Suppl. 1), S57-568. https://doi.org/10.1007/s00259-011-1771-7 (Original work published 2011)